Biotech和大药企全新合作方式,诞生

瞪羚社
Nov 03

上方“瞪羚社”即刻关注并加入社群聚焦高成长公司,15万+投资菁英共同关注谁说Biotech让大药企掏钱必须卖自家管线?一种很新的Biotech和大药企之间的交易合作方式已经出现。10月30日,药明巨诺与再生元Regeneron签署战略合作补充协议:再生元为药明巨诺的MAGE-A4靶点产品相关特定开发活动提供资金,再生元获得药明巨诺自研的药品生产工艺的全球非独家许可,并获得药明巨诺自研的慢病毒载体...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10